ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.
ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.
复制标题
DOI：
10.1097/aog.0000000000003892
复制
发表时间：
2019-01-01
影响因子：
7.2
通讯作者：
中科院分区：
文献类型：
--
作者：
妊娠期高血压疾病是全球孕产妇和围产儿死亡的主要原因之一。据估计，全球有2% - 8%的妊娠并发子痫前期。在拉丁美洲和加勒比地区，高血压疾病导致近26%的孕产妇死亡，而在非洲和亚洲，它们导致9%的死亡。尽管高收入国家的孕产妇死亡率远低于发展中国家，但16%的孕产妇死亡可归因于高血压疾病。在美国，1987年至2004年间子痫前期的发病率增加了25%。此外，与1980年分娩的女性相比，2003年分娩的女性患重度子痫前期的风险增加了6.7倍。这种并发症代价高昂：一项研究报告称，2012年在美国，分娩后12个月内子痫前期的估计费用为21.8亿美元（女性10.3亿美元，婴儿11.5亿美元），其中早产承担了不成比例的费用。本实践公告将为妊娠期高血压和子痫前期的诊断和管理提供指南。
Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2-8% of pregnancies globally (). In Latin America and the Caribbean, hypertensive disorders are responsible for almost 26% of maternal deaths, whereas in Africa and Asia they contribute to 9% of deaths. Although maternal mortality is much lower in high-income countries than in developing countries, 16% of maternal deaths can be attributed to hypertensive disorders (). In the United States, the rate of preeclampsia increased by 25% between 1987 and 2004 (). Moreover, in comparison with women giving birth in 1980, those giving birth in 2003 were at 6.7-fold increased risk of severe preeclampsia (). This complication is costly: one study reported that in 2012 in the United States, the estimated cost of preeclampsia within the first 12 months of delivery was $2.18 billion ($1.03 billion for women and $1.15 billion for infants), which was disproportionately borne by premature births (). This Practice Bulletin will provide guidelines for the diagnosis and management of gestational hypertension and preeclampsia.Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2-8% of pregnancies globally (). In Latin America and the Caribbean, hypertensive disorders are responsible for almost 26% of maternal deaths, whereas in Africa and Asia they contribute to 9% of deaths. Although maternal mortality is much lower in high-income countries than in developing countries, 16% of maternal deaths can be attributed to hypertensive disorders (). In the United States, the rate of preeclampsia increased by 25% between 1987 and 2004 (). Moreover, in comparison with women giving birth in 1980, those giving birth in 2003 were at 6.7-fold increased risk of severe preeclampsia (). This complication is costly: one study reported that in 2012 in the United States, the estimated cost of preeclampsia within the first 12 months of delivery was $2.18 billion ($1.03 billion for women and $1.15 billion for infants), which was disproportionately borne by premature births (). This Practice Bulletin will provide guidelines for the diagnosis and management of gestational hypertension and preeclampsia.